597 results on '"Dunn, Kelly E."'
Search Results
2. The Opioid Withdrawal Syndrome: Presentation, Measurement, and Management
3. Fentanyl
4. Supervised Withdrawal Opioid Use Disorder Treatments
5. Tramadol
6. Historical Events That Shaped Contemporary Opioid Trends
7. Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain
8. Establishing a research agenda for the study and assessment of opioid withdrawal
9. Diagnostic Ambiguities and Underuse of Clinical Assessment Tools: A Systematic Review of Case Reports on Kratom Addiction and Physical Dependence
10. Omissions, Ambiguities, and Underuse of Causal Assessment Tools: a Systematic Review of Case Reports on Patients Who Use Kratom
11. Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine
12. Opioid Use Disorder
13. Fentanyl
14. Tramadol
15. Supervised Withdrawal Opioid Use Disorder Treatments
16. Historical Events that Shaped Contemporary Opioid Trends
17. Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study
18. Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes
19. Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal.
20. The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawal
21. Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes.
22. The IMPOWR Network Divided or Single Exposure Study (DOSE) Protocol: A Randomized Controlled Comparison of Once Versus Split Dosing of Methadone for the Treatment of Comorbid Chronic Pain and Opioid Use Disorder
23. Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving Study
24. The Public Health Challenge of Δ8-THC and Derived Psychoactive Cannabis Products
25. Real-Time Monitoring of Cannabis and Prescription Opioid Co-Use Patterns, Analgesic Effectiveness, and the Opioid-Sparing Effect of Cannabis in Individuals With Chronic Pain
26. The association of chronic pain and opioid withdrawal in men and women with opioid use disorder
27. Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use
28. Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients
29. Gabapentin Enacarbil Extended‐Release for Alcohol Use Disorder: A Randomized, Double‐Blind, Placebo‐Controlled, Multisite Trial Assessing Efficacy and Safety
30. A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder
31. Pain as a Predictor and Consequence of Tobacco Abstinence Effects Amongst African American Smokers
32. Objective sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic review
33. Patient-reported sleep outcomes in randomized-controlled trials in persons with substance use disorders: A systematic review
34. Availability and Opportunities for Expansion of Buprenorphine for the Treatment of Opioid Use Disorder.
35. Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients
36. The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use
37. Effects of Early Life Trauma on Risks for Adult Opioid Use Disorder Are Mediated by Stress and Occur Independent of Depression and Anxiety
38. Knowledge, Preference, and Adverse Effects of Xylazine Among Adults in Substance Use Treatment
39. Intersectional Risk and the Significant Gap in Care for Persons with Co-occurring Chronic Pain and Opioid Withdrawal
40. Suvorexant alters dynamics of the sleep-EEG power spectrum and depressive symptom trajectories during inpatient opioid withdrawal
41. Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study
42. Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype–genotype assessment
43. Use of an electronic pillbox to increase number of methadone take-home doses during the COVID-19 pandemic
44. Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model
45. Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder
46. A preliminary examination of the multiple dimensions of opioid craving
47. The association of prefrontal cortex response during a natural reward cue-reactivity paradigm, anhedonia, and demoralization in persons maintained on methadone
48. Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain
49. Evidence of Buprenorphine-precipitated Withdrawal in Persons Who Use Fentanyl
50. Integration of Patient-reported Outcomes Assessment Into Routine Care for Patients Receiving Residential Treatment for Alcohol and/or Substance Use Disorder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.